A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangineto, Moris, Bukke, Vidyasagar Naik, Bellanti, Francesco, Tamborra, Rosanna, Moola, Archana, Duda, Loren, Villani, Rosanna, Romano, Antonino Davide, Serviddio, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923152/
https://www.ncbi.nlm.nih.gov/pubmed/33671262
http://dx.doi.org/10.3390/nu13020652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923152/
https://www.ncbi.nlm.nih.gov/pubmed/33671262
http://dx.doi.org/10.3390/nu13020652

Ejemplares similares